Expect Expect another drop below $4 today, treading in the $3 territory by the end of this week into next. This declining trend will continue with no support or Thomvest manipulation.
Did Liminal state that the plant was inspected and approved? If they were going to pay Kedrion to take this technology why would they have had the plant inspected? Is this a conditional FDA approval? They intend on closing Laval plant, probably because their scam is not welcome in Quebec anymore. Are they planning to build a new plant in Ontario or farm out Ryplasim production? Either way a lot more costs on the horizon.
The market doesn't like what it sees, the share price is bleeding not only because they will need funding, but because this is what Thomvest has always wanted.